Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

NCT00895960 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Sponsor withdrew support; Study did not progress to Phase II.

Conditions

Glioblastoma
CNS Disease
Brain Diseases

Interventions

DRUG: Dasatinib
RADIATION: RT (Radiotherapy)
DRUG: TMZ (Temozolomide)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]